[Editorial: Drugs and abnormalities. Background and consequences of warnings].
D000014:Abnormalities, Drug-Induced; D002231:Carbimazole / Q000009:adverse effects; D002994:Clofibrate / Q000009:adverse effects; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D008795:Metronidazole / Q000009:adverse effects; D011247:Pregnancy; D013723:Teratogens
D013723:Teratogens; D008795:Metronidazole; D002231:Carbimazole; D002994:Clofibrate
Medikamenter og misdannelser. Bakgrunn for og konsekvenser av advarsler